These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11865825)

  • 1. Hemodynamic consequences of neuropeptide Y-induced obesity.
    Correia ML; Morgan DA; Sivitz WI; Mark AL; Haynes WG
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):137-42. PubMed ID: 11865825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
    Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
    Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
    Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
    Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.
    Vettor R; Zarjevski N; Cusin I; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetologia; 1994 Dec; 37(12):1202-8. PubMed ID: 7895949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats.
    Sainsbury A; Cusin I; Rohner-Jeanrenaud F; Jeanrenaud B
    Diabetes; 1997 Feb; 46(2):209-14. PubMed ID: 9000696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
    Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
    Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective dependence of intracerebroventricular neuropeptide Y-elicited effects on central glucocorticoids.
    Zakrzewska KE; Sainsbury A; Cusin I; Rouru J; Jeanrenaud B; Rohner-Jeanrenaud F
    Endocrinology; 1999 Jul; 140(7):3183-7. PubMed ID: 10385413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
    Catzeflis C; Pierroz DD; Rohner-Jeanrenaud F; Rivier JE; Sizonenko PC; Aubert ML
    Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.
    Raposinho PD; Pierroz DD; Broqua P; White RB; Pedrazzini T; Aubert ML
    Mol Cell Endocrinol; 2001 Dec; 185(1-2):195-204. PubMed ID: 11738809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.
    Zarjevski N; Cusin I; Vettor R; Rohner-Jeanrenaud F; Jeanrenaud B
    Endocrinology; 1993 Oct; 133(4):1753-8. PubMed ID: 8404618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation.
    Parikh R; Marks JL
    J Neuroendocrinol; 1997 Oct; 9(10):789-95. PubMed ID: 9355048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure.
    Correia ML; Morgan DA; Sivitz WI; Mark AL; Haynes WG
    Hypertension; 2001 Mar; 37(3):936-42. PubMed ID: 11244021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action by neuropeptide Y (NPY) and norepinephrine (NE) on food intake, metabolic rate, and brown adipose tissue (BAT) causes remarkable weight loss in the obese (fa/fa) Zucker rat.
    al-Arabi A; Andrews JF
    Biomed Sci Instrum; 1997; 33():216-25. PubMed ID: 9731362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways.
    Preston E; Cooney GJ; Wilks D; Baran K; Zhang L; Kraegen EW; Sainsbury A
    Neuropeptides; 2011 Dec; 45(6):407-15. PubMed ID: 21862125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression.
    Raposinho PD; Pedrazzini T; White RB; Palmiter RD; Aubert ML
    Endocrinology; 2004 Jan; 145(1):304-10. PubMed ID: 14525913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebroventricular administration of NPY increases sympathetic tone selectively in vascular beds.
    Hu Y; Dunbar JC
    Brain Res Bull; 1997; 44(1):97-103. PubMed ID: 9288836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular neuropeptide Y injections stimulate food intake in lean, but not obese Zucker rats.
    Brief DJ; Sipols AJ; Woods SC
    Physiol Behav; 1992 Jun; 51(6):1105-10. PubMed ID: 1641411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats.
    Bishop C; Parker GC; Coscina DV
    Psychopharmacology (Berl); 2002 Jul; 162(3):265-72. PubMed ID: 12122484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
    Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
    Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.